Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance

R. A. Devasia(Vanderbilt University), Timothy R. Sterling(Vanderbilt University Medical Center), Ayumi Shintani(Vanderbilt University Medical Center), Nicholas Hooper(Maryland State Department of Education), Svetlana Eden(Vanderbilt University Medical Center), Amondrea Blackman(Vanderbilt University Medical Center), Christopher May(University of Michigan), Fernanda Maruri(Vanderbilt University), Teresa Smith(Tennessee Department of Health), Charles W. Stratton(Vanderbilt University Medical Center)
Journal of Antimicrobial Chemotherapy
March 28, 2009
10.1093/jac/dkp096
Cited by 49

Related Papers

Long-Term Cognitive Impairment after Critical Illness
|New England Journal of Medicine|2013|2.8k
Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
|The Lancet|2008|2k
Monitoring Sedation Status Over Time in ICU Patients
|JAMA|2003|1.7k
Long-Term Cognitive Impairment After Critical Illness
|Survey of Anesthesiology|2014|1.1k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k